PARGY-LAD
From Wikipedia, the free encyclopedia
 |
|
|
PARGY-LAD
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C22H25N3O |
| Mol. mass | 347.46 g/mol |
| Synonyms | PARGY-LAD, 6-propynyl-6-nor-Lysergic acid diethylamide |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
PARGY-LAD, also known as 6-propynyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PARGY-LAD is a hallucinogenic drug similar to LSD, but is slightly less potent than LSD with a dose of 160 micrograms producing only mild effects, and 500 micrograms required for full activity.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
AL-LAD, ALD-52, BU-LAD, CYP-LAD, Diallyllysergamide, DAM-57, Ergonovine, ETH-LAD, LAE-32, LSD, LPD-824, LSM-775, Methylergonovine, MLD-41, PARGY-LAD, PRO-LAD
